CLINICAL_TRIALS
trial_result
· 2023-07-18
Clinical Trial Update: Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial update on efficacy and safety of semaglutide injection in adults with Type 2 Diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: UNKNOWN